Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-002500
Filing Date
2013-01-08
Accepted
2013-01-08 19:04:33
Documents
2
Period of Report
2013-01-07

Document Format Files

Seq Description Document Type Size
1 EHRLICH ANNUAL GRANT rrd366344.html 4  
1 EHRLICH ANNUAL GRANT rrd366344.xml 4 3725
2 POWER OF ATTORNEY rrd328941_371764.htm EX-24. 4763
  Complete submission text file 0001181431-13-002500.txt   10007
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025
Business Address
Ehrlich Christopher B (Reporting) CIK: 0001293973 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 13519260